Peroxisome proliferator-activated receptor-γ2 P12A and type 2 diabetes in Canadian Oji-Cree

被引:67
作者
Hegele, RA
Cao, H
Harris, SB
Zinman, B
Hanley, AJG
Anderson, CM
机构
[1] Univ Western Ontario, Blackburn Cardiovasc Genet Lab, John P Robarts Res Inst, London, ON N6A 5K8, Canada
[2] Univ Western Ontario, Ctr Studies Family Med, London, ON N6A 5K8, Canada
[3] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[4] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada
关键词
D O I
10.1210/jc.85.5.2014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among the Oji-Cree of northern Ontario, we previously identified a novel variant in the HNF1A gene, namely G319S, that was strongly associated with type 2 diabetes. However, the majority of subjects with diabetes did not have the HNF1A S319 variant, suggesting that there might be other genetic determinants of diabetes susceptibility. In the course of sequencing candidate genes in diabetic subjects who were homozygous for HNF1A G319/G319, we found that some of them had the PPARG A12 variant. After genotyping PPARG in the entire adult Oji-Cree population, we found that: 1) PPARG A12 was strongly associated with type 2 diabetes in women, but not men; 2) among women, the odds of being affected for carriers of PPARG A12 compared with noncarriers was 2.3 (95% confidence interval, 1.4-3.8); and 3) among women, affected carriers of PPARG A12 had a significantly earlier age-of-onset and/or age-at-diagnosis compared with noncarriers. When taken together with the previously reported association of diabetes with HNF1A in both men and women, the gender-specific association with PPARG A12 confirms that type 2 diabetes is etiologically complex in the Oji-Cree and that at least two genes are involved in determining susceptibility to the disease in these people.
引用
收藏
页码:2014 / 2019
页数:6
相关论文
共 24 条
[1]  
[Anonymous], WHO TECHN REP SER
[2]   Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene [J].
Beamer, BA ;
Negri, C ;
Yen, CJ ;
Gavrilova, O ;
Rumberger, JM ;
Durcan, MJ ;
Yarnall, DP ;
Hawkins, AL ;
Griffin, CA ;
Burns, DK ;
Roth, J ;
Reitman, M ;
Shuldiner, AR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) :756-759
[3]   Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations [J].
Beamer, BA ;
Yen, CJ ;
Andersen, BE ;
Muller, D ;
Elahi, D ;
Cheskin, LJ ;
Andres, R ;
Roth, J ;
Shuldiner, AR .
DIABETES, 1998, 47 (11) :1806-1808
[4]   A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity [J].
Deeb, SS ;
Fajas, L ;
Nemoto, M ;
Pihlajamäki, J ;
Mykkänen, L ;
Kuusisto, J ;
Laakso, M ;
Fujimoto, W ;
Auwerx, J .
NATURE GENETICS, 1998, 20 (03) :284-287
[5]   The organization, promoter analysis, and expression of the human PPAR gamma gene [J].
Fajas, L ;
Auboeuf, D ;
Raspe, E ;
Schoonjans, K ;
Lefebvre, AM ;
Saladin, R ;
Najib, J ;
Laville, M ;
Fruchart, JC ;
Deeb, S ;
VidalPuig, A ;
Flier, J ;
Briggs, MR ;
Staels, B ;
Vidal, H ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18779-18789
[6]   Specific patterns of food consumption and preparation are associated with diabetes and obesity in a native Canadian community [J].
Gittelsohn, J ;
Wolever, TMS ;
Harris, SB ;
Harris-Giraldo, R ;
Hanley, AJG ;
Zinman, B .
JOURNAL OF NUTRITION, 1998, 128 (03) :541-547
[7]   Serum immunoreactive leptin concentrations in a Canadian Aboriginal population with high rates of NIDDM [J].
Hanley, AJG ;
Harris, SB ;
Gao, XJ ;
Kwan, J ;
Zinman, B .
DIABETES CARE, 1997, 20 (09) :1408-1415
[8]  
HARRIS M, 1979, DIABETES, V28, P1039
[9]   The prevalence of NIDDM and associated risk factors in native Canadians [J].
Harris, SB ;
Gittelsohn, J ;
Hanley, A ;
Barnie, A ;
Wolever, TMS ;
Gao, J ;
Logan, A ;
Zinman, B .
DIABETES CARE, 1997, 20 (02) :185-187
[10]   The hepatic nuclear factor-1α G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree [J].
Hegele, RA ;
Cao, HI ;
Harris, SB ;
Hanley, AJG ;
Zinman, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) :1077-1082